EMERALD MUTUAL FUND ADVISERS TRUST
Q1 2014 13F-HR Holdings
Net value change ($000)
+164,048
(18.6%)
New positions
36
Sold out positions
25
Turnover %
12.7%
Sector allocation + QoQ delta (equities-only)
Snapshot: Change Analysis
Compared to Q4 2013
Methodology:
sector metrics are equities-only;
instrument mix chart is ex-options;
options exposure is shown separately.
Why this matters.
Top Adds (Value $000, Stocks/ETFs)
| Kate Spade & Co | 13,716 | NEW |
| INTERMUNE INC | 9,812 | NEW |
| FLYYQ | 9,799 | 50.1% |
| Horizon Therapeutics PLC Com | 9,614 | NEW |
| KFRC | 8,363 | NEW |
| BANK OF THE OZARKS | 5,587 | 29.2% |
| TREX | 5,204 | 27.2% |
| SVB FINANCIAL GROUP | 5,010 | 30.6% |
| MBUU | 4,829 | NEW |
| PACWEST BANCORP | 4,143 | 80.7% |
Top Reduces (Value $000, Stocks/ETFs)
| FIFTH & PAC COS INC | -8,881 | -100.0% |
| MTH | -5,738 | -100.0% |
| *SYNAGEVA BIOPHARMA CORP | -4,558 | -100.0% |
| BIND THERAPEUTICS INC | -3,886 | -94.4% |
| INFOBLOX INC | -3,686 | -31.7% |
| IXIA | -3,661 | -60.8% |
| TMHC | -3,398 | -100.0% |
| *AEGERION PHARMACEUTICALS INC | -3,294 | -100.0% |
| AKORN INC | -3,246 | -100.0% |
| INSYS THERAPEUTICS INC | -3,138 | -100.0% |
Instrument mix + QoQ Δ (ex-options)
How this table is calculated:
SEC
VALUE ($000) is used as reported.
For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received.
Column % is bucket-based:
non-options share is calculated inside non-option total, options share is calculated inside options total.
Details.
Filter:
Instrument:
| Issuer Name | Ticker | Sector | Industry | Class | History | Value ($000) | % | Shares | Shares Δ | Shares Δ% | Value Δ ($000) | Value Δ% | Principal | Option Type |
|---|